GW572016
Term · Oncology and biomedicine · MLC-T-ONC-003698
A drug used with capecitabine or letrozole to treat certain types of HER2-positive breast cancer that are advanced or have spread. It is also being studied in the treatment of other types of cancer. GW572016 blocks EGFR and other proteins, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called lapatinib ditosylate and Tykerb.
| Identifier | MLC-T-ONC-003698 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | lapatinib ditosylate; Tykerb |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003698",
"term": "GW572016",
"field": "Oncology and biomedicine",
"definition": "A drug used with capecitabine or letrozole to treat certain types of HER2-positive breast cancer that are advanced or have spread. It is also being studied in the treatment of other types of cancer. GW572016 blocks EGFR and other proteins, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called lapatinib ditosylate and Tykerb.",
"expansions": [
"lapatinib ditosylate",
"Tykerb"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/gw572016/"
}
Record 8,238 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.